{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:41:48Z","timestamp":1768966908958,"version":"3.49.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4042-19","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T22:08:40Z","timestamp":1602713320000},"page":"2529-2537","source":"Crossref","is-referenced-by-count":2,"title":["Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1"],"prefix":"10.2169","volume":"59","author":[{"given":"Masanori","family":"Iwanishi","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choka","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tezuka","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ito-Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Washiyama","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Kikugawa","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Liu W, Morito D, Takashima S, et al. Identification of RNF 213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLOS one 6: e22542, 2011.","DOI":"10.1371\/journal.pone.0022542"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF 213 as the first Moyamoya didease gene. J Hum Genet 56: 34-40, 2011.","DOI":"10.1038\/jhg.2010.132"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 360: 1226-1237, 2009.","DOI":"10.1056\/NEJMra0804622"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cao Y, Kobayashi H, Morimoto K, et al. Frequency of RNF 213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Environ Health Prev Med 21: 387-390, 2016.","DOI":"10.1007\/s12199-016-0549-8"},{"key":"5","unstructured":"5. Miyawaki S, Imai H, Shimizu M. Genetic variant RNF 213 c. 14576G&gt;A in various phenotypes of intracranial major artery stenosis\/occlusion. Stroke 44: 2894-2897, 2013."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morimoto T, Mineharu Y, Ono K, et al. Significant association of RNF 213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. PLoS one 12: e0175649, 2017.","DOI":"10.1371\/journal.pone.0175649"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sugihara M, Morito D, Ainuki S, et al. The AAA+ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets. J. Cell Biol 218: 949-960, 2019.","DOI":"10.1083\/jcb.201712120"},{"key":"8","unstructured":"8. Iwanishi M, Kusakabe T, Azuma C, et al. Clinical characteristics of 15 female Japanese patients with partial lipodystrophy identified in a diabetic outpatient clinic. Diabetes Updates. Forthcoming."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Iwanishi M, Ebihara K, Kusakabe T, et al. Premature atherosclerosis in a Japanese diabetic patient with atypical familial partial lipodystrophy and hypertriglyceridemia. Intern Med 51: 2573-2579, 2012.","DOI":"10.2169\/internalmedicine.51.7461"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iwanishi M, Ito-Kobayashi J, Washiyama M, et al. Clinical characteristics, phenotype of lipodystropy and genetic analysis of six Japanese female patients with partial lipodystrophy in a diabetic outpatient clinic. Intern Med 57: 2301-2313, 2018.","DOI":"10.2169\/internalmedicine.0225-17"},{"key":"11","unstructured":"11. Akinci B, Sahinoz M, Oral E. Lipodystrophy Syndrome: Presentation and Treatment Endotext [Internet]. MDText. com, Inc, South Dartmouth (MA), 2018: 2000."},{"key":"12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","volume":"26","author":"KI Herbst","year":"2003","unstructured":"12. Herbst KI, Purnell JQ, Tannock LR, et al. K\u00f6bberling type of familial partial lipodystrophy. Diabetes Care 26: 1819-1824, 2003.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"13","unstructured":"13. Guillin-Amarella C, Sanchez-Iglesias S, Castro-Pais A, et al. Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome. Endocrine 54: 411-421, 2016."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Morito D, Nishikawa K, Hoseki J, et al. Moyamoya disease-associated protein mysterin\/RNF 213 is a novel AAA + ATPase, which dynamically changes its oligomeric state. Sci Rep 4: 4442, 2014.","DOI":"10.1038\/srep04442"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306: 1383-1386, 2004.","DOI":"10.1126\/science.1100747"},{"key":"16","unstructured":"16. Zechner R, Madeo F, Kratky D. Cytosolic lipolysis and lipophagy: two sides of the same coin. Nat Rev Mol Cell Biol 18: 671-684, 2017."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kobayashi H, Matsuda Y, Hitomi T. Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis <i>in vitro<\/i> and <i>in Vivo<\/i>. J Am Heart Assoc 4: e002146, 2015.","DOI":"10.1161\/JAHA.115.002146"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Morimoto T, Enmi JI, Hattori Y. Dysregulation of RNF 213 promotes cerebral hypoperfusion. Sci Rep 8: 3607, 2018.","DOI":"10.1038\/s41598-018-22064-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mineharu Y, Takagi Y, Takahashi J, et al. Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF 213 risk variant. Cerebrovasc Dis 36: 155-157, 2013.","DOI":"10.1159\/000352065"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matsuda Y, Mineharu Y, Kimura M, et al. RNF213 p.R4810K variant and intracranial arterial stenosis or occlusion in relatives of patients with moyamoya disease. J Stroke Cerebrovasc Dis 26: 1841-1847, 2017.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Morimoto T, Mineharu Y, Kobayashi H, et al. Significant association of the RNF213 p.R4810K polymorphism with quasi-moyamoya disease. J Stroke Cerebrovasc Dis 25: 2632-2636, 2016.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.004"},{"key":"22","unstructured":"22. Chong PF, Ogata R, Kobayashi H, et al. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.4810K. Brain Dev 37: 822-824, 2015."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Corvillo F, Aparicio V, Lopez-Lera A. Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy. Front Immunol 9: 2142, 2018.","DOI":"10.3389\/fimmu.2018.02142"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Koizumi A, Kobayashi H, Hitomi T, et al. A new horizon of moyamoya disease and associated health risks explored through RNF 213. Environ Health Prev Med 21: 55-70, 2016.","DOI":"10.1007\/s12199-015-0498-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4042-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:44:08Z","timestamp":1602906248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4042-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":24,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4042-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}